Literature DB >> 6235988

Tumour-induced suppressor macrophages in rats: differences in their suppressive effects on the Con A and PHA responses.

Y Mizushima, H T Wepsic, Y Yamamura, M A Desilva.   

Abstract

Spleen cells obtained from ACI rats bearing a syngeneic hepatoma (9098) (TBR spleen cells) showed a strongly depressed mitogen responses to concanavalin A (Con A) and to phytohaemagglutinin-P (PHA) at various concentrations of the tested mitogens. The activity of suppressor cells in TBR spleens was demonstrated in mixtures with normal spleen cells where a marked depression of the mitogen response was observed. The properties of tumour-induced suppressor cells were adherent to plastic or nylon wool, phagocytic, and radioresistant (maybe macrophages). The Con A response of TBR spleen cells was more completely restored than was the PHA response after the removal of adherent or phagocytic cells. The suppression when TBR spleen cells (2,000 rad) were added to normal spleen cells at 0, 24, and 45 h after culture initiation was greater in the PHA response than in the Con A response. The PHA assay appeared to be more sensitive method than the Con A assay for the detection of suppressor cell activity in tumour bearing rats.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235988      PMCID: PMC1536109     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  In vitro studies of the rabbit immune system. IV. Differential mitogen responses of isolated T and B cells.

Authors:  H W Sheppard; D Redelman; S Sell
Journal:  Cell Immunol       Date:  1976-06-01       Impact factor: 4.868

2.  Phytohemagglutinin-induced proliferation of guinea pig thymus-derived lymphocytes. I. Accessory cell dependence.

Authors:  P E Lipsky; J J Ellner; A L Rosenthal
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

3.  Role of adherent cells in immune responses to phytohemagglutinin and concanavalin A.

Authors:  M P Arala-Chaves; L Hope; J H Korn; H Fudenberg
Journal:  Eur J Immunol       Date:  1978-02       Impact factor: 5.532

4.  BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro.

Authors:  G R Klimpel; C S Henney
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

5.  Role of macrophages in the tumor-induced suppression of mitogen responses in rats.

Authors:  A M Kruisbeek; M van Hees
Journal:  J Natl Cancer Inst       Date:  1977-06       Impact factor: 13.506

6.  Functional heterogeneity of murine lymphoid cells. 3. Differential responsiveness of T cells to phytohemagglutinin and concanavalin A as a probe for T cell subsets.

Authors:  J D Stobo; W E Paul
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

7.  Absolute macrophage dependency of T lymphocyte activation by mitogens.

Authors:  D L Rosenstreich; J J Farrar; S Dougherty
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

8.  Changes in the mitogen response of lymphoid cells with progressive tumor growth.

Authors:  R W Gillette; C W Boone
Journal:  Cancer Res       Date:  1975-12       Impact factor: 12.701

9.  Inhibition of the graft-versus-host response by BCGcw-induced suppressor cells or prostaglandin E1.

Authors:  S M Wren; H T Wepsic; C H Larson; M A De Silva; Y Mizushima
Journal:  Cell Immunol       Date:  1983-03       Impact factor: 4.868

10.  Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.

Authors:  H Kirchner; T M Chused; R B Herberman; H T Holden; D H Lavrin
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

View more
  1 in total

1.  Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro.

Authors:  C Schebesch; V Kodelja; C Müller; N Hakij; S Bisson; C E Orfanos; S Goerdt
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.